Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinobiopharma Announces Improved Q2

publication date: Jan 19, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinobiopharma reported greatly improved financial results for its Q2 (ended November 30, 2009). The company said revenues jumped 120% to $2.1 million and net income was $1.1 million, a $2.1 million increase from the year-earlier quarter. Sinobiopharma attributed the rise in revenue to continuing marketing of its major revenue driver, the muscle relaxant KuTai (cisatracurium besylate). More details..

Stock Symbol: (OTCBB: SNBP)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners